As of April 2024 Organogenesis has a market cap of $0.37 Billion. This makes Organogenesis the world's 6259th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.37 B | -29.73% |
2023 | $0.53 B | 52.51% |
2022 | $0.35 B | -70.37% |
2021 | $1.18 B | 23.59% |
2020 | $0.96 B | 90.68% |
2019 | $0.50 B | -45.98% |
2018 | $0.93 B | 203.62% |
2017 | $0.30 B |
On Apr 18th, 2024 the market cap of Organogenesis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.85 B | 127.15% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -94.46% | ๐บ๐ธ USA |